London, UK – 30th March 2026 – Prescient (Prescient Healthcare Group) has acquired London-based pricing and market access consultancy Dolon, strengthening its ability to support global biopharma companies navigating increasingly complex and interconnected clinical, commercial and market access environments.
Following the successful acquisition of healthcare consultancy Uptake (Uptake Strategies) earlier this year, the addition of Dolon represents the next step in Prescient’s rapid growth journey, significantly enhancing the breadth of Prescient’s offer to the market.
Dolon will retain its specialist focus, joining as a dedicated Value, Pricing and Access practice working alongside Prescient’s established teams. For clients, the partnership will deliver seamless, comprehensive support for complex challenges, ensuring vital strategic pricing and market access insights inform pivotal decisions earlier and further across the product lifecycle.
The partnership delivers significant new opportunities for both parties and supports Dolon’s next phase of growth within a broader global platform.